Effects of Plant-Based Diet on Peripheral Arterial Disease
NCT03798938 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2019-01-10
Summary
Cardiovascular disease (CVD), a condition predominantly caused by atherosclerosis, is the leading cause of morbidity and mortality in the investigator's society. Peripheral arterial disease (PAD), a subset of CVD, occurs when the atherosclerosis progresses to compromise the lower extremity circulation resulting in ischemic symptoms. Although atherosclerosis has been generally regarded as a disease of developed or affluent countries, recent evidence showed a progressive rise in the prevalence of CVD in developing countries where an epidemiological shift of disease prevalence patterns from infectious illnesses to atherosclerotic disease has occurred. Management of CVD, particularly with an emphasis of disease prevention, will undoubtedly play an increasing vital role in the health care system around the world.
Endothelial dysfunction, as reflected by the impaired arterial vasodilatory capacity, represents one of the pathogenic mechanisms linking atherosclerosis and cardiovascular mortality. The ability of arteries to dilate in response to stimuli is a significant indicator of underlying vascular endothelial function and associated CVD. Factors modulating vasodilatory response include the release of vasoactive compounds such as nitric oxide (NO) from the endothelium and vascular compliance. In healthy individuals, a major mechanism responsible for vasodilation is the hyperemic-stimulated release of NO from the endothelium, resulting in vascular smooth muscle relaxation with subsequent vasodilation.
Vascular endothelial function can be assessed using a non-invasive technique to determine brachial artery reactivity whereby a high-resolution ultrasound is used to measure changes in brachial artery diameter to endogenous production of endothelium-derived NO via flow-mediated dilation (FMD). Therefore, reduced FMD has been described as a reliable indicator of vascular endothelial dysfunction as well as presence of underlying CVD risk factors and related diseases. Recent studies have similarly shown that arterial pulse-wave velocity (PWV), which is a non-invasive evaluation of arterial stiffness, is a reliable indicator of vascular function. While numerous studies have documented the benefit of dietary intervention in the reduction of CVD related sequelae, limited data is available regarding whether the beneficial effect of dietary intervention are reflected in vascular endothelial function. The present study was therefore conducted to assess the effects of plant-based diet (PBD) on vascular endothelial function as assessed by FMD and PWV in patients with peripheral arterial disease (PAD).
Conditions
- Peripheral Arterial Disease
Interventions
- OTHER
-
plant-based diet
subjects will be placed in plant-based diet and the effect of plant-based diet to the endothelial function will be monitored
Sponsors & Collaborators
-
Vascular Institute of Texas
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-01-10
- Primary Completion
- 2019-06-10
- Completion
- 2019-10-10
Countries
- United States
Study Locations
More Related Trials
-
The Effects of Oral Inorganic Nitrate Supplementation on Lower Limb Perfusion During Exercise in Patients With PAD
NCT05036213 ·Status: RECRUITING ·Phase: PHASE1
-
Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes.
NCT03921905 ·Status: COMPLETED
-
Stop Atherosclerosis in Native Diabetics Study
NCT00147251 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation
NCT01682889 ·Status: COMPLETED ·Phase: PHASE4
-
Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest
NCT03149406 ·Status: UNKNOWN
-
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
NCT03506633 ·Status: COMPLETED ·Phase: NA
-
Lp-PLA2 and Coronary Atherosclerosis in Humans
NCT01557088 ·Status: COMPLETED ·Phase: NA
-
Nitrites, Exercise, and Peripheral Arterial Disease
NCT01684930 ·Status: COMPLETED ·Phase: PHASE2
-
BEETroot Juice to Reverse Functional Impairment in PAD
NCT05624125 ·Status: RECRUITING ·Phase: NA
-
L-Arginine in the Treatment of Peripheral Arterial Disease
NCT00284076 ·Status: COMPLETED ·Phase: NA
-
Best Practice Advisory to Initiate High-Intensity Statin Therapy in Patients With Peripheral Artery Disease
NCT05166187 ·Status: COMPLETED ·Phase: NA
-
Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease
NCT02388971 ·Status: WITHDRAWN ·Phase: PHASE2
-
Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes
NCT01419418 ·Status: COMPLETED
-
Implementation of Vascular Care Team to Improve Medical Management of PAD Patients
NCT04400409 ·Status: COMPLETED ·Phase: NA
-
Effect of Neo40 on PAD
NCT02934438 ·Status: UNKNOWN ·Phase: NA
-
Molecular Mechanisms and Carotid Atherosclerosis
NCT03962686 ·Status: COMPLETED
-
Angiotensin-(1-7) in Peripheral Arterial Disease
NCT03240068 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis
NCT02124928 ·Status: UNKNOWN
-
The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early Atherosclerosis
NCT01067326 ·Status: TERMINATED ·Phase: PHASE3
-
Physiopathological and Therapeutic Value of microRNA in the Progression of Carotid Artery Plaques: Carotid Protocol and microRNA
NCT02804659 ·Status: UNKNOWN
-
A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.
NCT05984537 ·Status: RECRUITING ·Phase: PHASE4
-
NAD Supplementation and Vascular Health in PAD
NCT06534944 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)
NCT00399919 ·Status: COMPLETED ·Phase: PHASE3
-
Bacteria in Atherosclerotic Plaques and Adverse Events
NCT06935279 ·Status: COMPLETED
-
Lifestyle Modification Programme for Patients With Asymptomatic Carotid Artery Stenosis
NCT03929354 ·Status: UNKNOWN ·Phase: NA